TNF-α is a key regulator of immunological responses, and its aberrant production underlies the pathogenesis of many human diseases, in particular acute and chronic inflammatory diseases [22], for which TNF-blocking agents have become an established treatment, as for IBD [23]. This evidence concerns the gene TNF and inflammatory bowel disease.